OPTIONS Spinal Cord Stimulation Programming Parameters
Status: | Active, not recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/17/2016 |
Start Date: | July 2015 |
End Date: | January 2017 |
A Prospective, Multi-center, Open-label Study of Programming Options in Spinal Cord Stimulation.
The purpose of this study is to evaluate programming options in spinal cord stimulation for
the management of chronic, intractable pain of the trunk and limbs.
the management of chronic, intractable pain of the trunk and limbs.
Prospective, multi-center, open-label study evaluating programming options in spinal cord
stimulation on pain relief. All eligible subjects will undergo a Spinal Cord Stimulation
(SCS) device trial that includes an intraoperative programming trial. Subjects experiencing
a positive response to the programming parameters (improvement in average overall pain
relief) during the trial from baseline will move forward with a permanent implant. Those not
reporting a positive response to the programming parameters will be exited from the study.
The subjects will complete a number of assessment worksheets to characterize their Quality
of Life and function and the level of pain they are experiencing from the baseline to 3
months post neurostimulation trial.
stimulation on pain relief. All eligible subjects will undergo a Spinal Cord Stimulation
(SCS) device trial that includes an intraoperative programming trial. Subjects experiencing
a positive response to the programming parameters (improvement in average overall pain
relief) during the trial from baseline will move forward with a permanent implant. Those not
reporting a positive response to the programming parameters will be exited from the study.
The subjects will complete a number of assessment worksheets to characterize their Quality
of Life and function and the level of pain they are experiencing from the baseline to 3
months post neurostimulation trial.
Inclusion Criteria:
- Candidate for Spinal Cord Stimulation (SCS) system (trial and implant) per labeled
indication(back and leg pain)
- Willing and able to provide a signed and dated informed consent
- At least 18 years old at the time of informed consent
- Willing and able to attend visits and comply with the study protocol
- Capable of using the patient programmer and recharging the neurostimulator
- Willing to not increase pain medications from baseline through the 3-Month Visit
Exclusion Criteria:
- Currently enrolled in or plans to enroll in any concurrent drug and/or device study
that may confound study results.
- Psychological or other health conditions that would interfere with the subject's
ability to fulfill the requirements of the protocol.
- Trialed or implanted with SCS, subcutaneous stimulation, peripheral nerve stimulation
or an implantable intrathecal drug delivery system
- Implanted with a cardiac device (e.g., pacemaker, defibrillator)
We found this trial at
11
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials